Asthma and Chronic obstructive pulmonary disease (COPD) devices are mainly used as rescue therapy for diseases related to respiration. Asthma and COPD both show similar kinds of symptoms such as wheezing, coughing, and shortness of breath. But, COPD generally outlines progressive respiratory diseases such as chronic bronchitis and emphysema. Moreover, there are decreased levels of respiratory airflow and the inflammation of airway tissues in the case of COPD. According to the National Institutes of Health (NIH), more than 16 million Americans are suffering from the chronic obstructive pulmonary disease (COPD)

ALSO READ : http://www.marketwatch.com/story/copd-and-asthma-diagnostic-and-mon...
The demand for COPD and Asthma Diagnostic and Monitoring Devices is increasing on account of the rising incidence of Asthma and COPD cases, rise in the aging population, growing population of tobacco smokers, increase in Urbanization and pollution, rising case of preterm birth, and lifestyle changes. Furthermore, increasing government initiatives and the focus of pharmaceutical companies to manufacture an advanced and portable inhalation device, further drives the market growth. For instance, Lupin launched “Adhero”, a connected smart drug delivery device in India for the treatment of respiratory diseases such as COPD and Asthma. Ahereo can be attached to a metered-dose inhaler (MDI), having Bluetooth-like features which can be used to track the daily medication record of patients through “MyAdhero” on smartphones. However, some of the restraints in the market include the high cost of devices, and degradation of material quality after some time.
Based on Therapeutic devices, the market is fragmented into Ventilator, Mask, PAP (Positive airway pressure) Device, Inhaler, and Nebulizer. Inhalers sub-segment is expected to dominate the market owing to its low coordination with the patient and easy to use feature. Inhalers are generally of two types metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs). MDI provides slow deep inhalation and is propellant based while DPI provides rapid deep inhalation and is non-propellant-based. German Remedies launched “Novolizer” is a (DPI) approved for use with salbutamol (albuterol) and budesonide, for the treatment of Asthma and COPD attacks.
Based on Monitoring devices, the market is segmented into Pulse Oximeters, Capnography, and Gas Analyzers. The pulse oximeters segment is expected to dominate the market owing to its fast and accurate results. Furthermore, the rising awareness regarding the applications of a pulse oximeter in Covid-19 management and the high prevalence of respiratory diseases also propels the market growth. Based on Diagnostic devices, the market is fragmented into Spirometers, Polysomnography (PSG) Devices, Peak Flow Meters, and Other Diagnostic Devices. Peak flow Meter devices are expected to dominate the market in the upcoming period owing to their lightweight, easy to handle, and store. Furthermore, these devices can be connected remotely for the diagnosis of respiration rate. For instance, “The Microlife PF 100” is a digital measuring device for the detection of peak expiratory flow (PEF) as well as forced expiratory volume for the monitoring of respiration rate in asthmatic patients.

ALSO READ : http://www.marketwatch.com/story/purity-metal-target-market-researc...
Based on Indication, the market is segmented into Asthma and COPD. The Asthma sub-segment is expected to dominate the market owing to the rise in outdoor and indoor causative agents such as allergens, dust, and pollution. As per World Health Organization (2019), Asthma affected an estimated 262 million people in 2019 and caused 461000 deaths, worldwide. Based on End-user, the market is fragmented into Homecare, Hospitals, Clinics, and Other end-users. Hospital sub-segment is expected to dominate the market owing to an increase in the number of patients suffering from respiratory diseases, a rise in government initiatives, and advancements In technology in terms of COPD and asthma devices.

ALSO READ : http://www.marketwatch.com/story/empagliflozin-api-market-research-...
For a better understanding of the market adoption of the COPD and Asthma Diagnostic and Monitoring Devices, the market is analyzed for major regions including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America dominated the market in 2020, on account of the highly developed healthcare infrastructure, huge healthcare spending, and presence of a large number of market players in the US. As per the Asthma and Allergy Foundation of America, around 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children.
Some of the major players operating in the market include Drägerwerk AG & CO. KGAA, Getinge AB, Invacare Corporation, Masimo Corporation, Vyaire Medical Inc., Koninklijke Philips N.V, Becton Dickinson And Company, Nihon Kohden Corporation, Smiths Medical, and Medtronic plc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Limitations
1.3 Stake Holders
1.4 Currency Used in Report
2 RESEARCH PROCESS & RESEARCH METHODOLOGY
2.1 Research Process of the COPD and Asthma Diagnostic and Monitoring Devices Market
2.2 Research Methodology of the COPD and Asthma Diagnostic and Monitoring Devices Market
2.3 Forecasting Method
2.4 Respondent Profile
2.5 Main Objective of the COPD and Asthma Diagnostic and Monitoring Devices Market Study
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS 2019-27F
6 MARKET INSIGHTS BY THERAPEUTIC DEVICES
6.1 Ventilator
6.2 Mask
6.3 PAP (Positive Airway Pressure) Device
6.4 Inhaler
6.5 Nebulizer
7 MARKET INSIGHTS BY MONITORING DEVICES
7.1 Pulse Oximeters
7.2 Capnographs
7.3 Gas Analysers
8 MARKET INSIGHTS BY DIAGNOSTIC DEVICES
8.1 Spirometers
8.2 Polysomnography (PSG) Devices
8.3 Peak Flow Meters
8.4 Other Diagnostic Devices
9 MARKET INSIGHTS BY INDICATION
9.1 Asthma
9.2 COPD
10 MARKET INSIGHTS BY END-USER
10.1 Homecare
10.2 Hospitals
10.3 Clinics
10.4 Other end-users
11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Italy
11.2.5 Spain
11.2.6 Rest of Europe
11.3 ASIA PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 Rest of Asia Pacific
11.4 REST OF WORLD COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
12 Demand and Supply Side Analysis
12.1 Demand Side Analysis
12.2 Supply Side Analysis
12.1.1 Top Product Launches
12.1.2 Top Business Partnerships
12.1.3 Top Business Exapnsions, Investments and Diverstitures
12.1.4 Top Merger and Acquisitions
13 Value Chain Analysis
14 Global COPD and Asthma Diagnostic and Monitoring Devices Market Trends & Insights
15 Global COPD and Asthma Diagnostic and Monitoring Devices Market Dynamics
15.1 Drivers
15.2 Challenges

…continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105